Dynavax Technologies
DVAX
#5495
Rank
ยฃ0.95 B
Marketcap
ยฃ8.17
Share price
-0.64%
Change (1 day)
-19.13%
Change (1 year)

Revenue for Dynavax Technologies (DVAX)

Revenue in 2025 (TTM): ยฃ0.25 Billion

According to Dynavax Technologies 's latest financial reports the company's current revenue (TTM ) is ยฃ0.24 Billion. In 2024 the company made a revenue of ยฃ0.22 Billion an increase over the revenue in the year 2023 that were of ยฃ0.18 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Dynavax Technologies from 2004 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) ยฃ0.25 B13.27%
2024 ยฃ0.22 B21.17%
2023 ยฃ0.18 B-69.48%
2022 ยฃ0.59 B83.49%
2021 ยฃ0.32 B853.25%
2020 ยฃ34.15 M27.16%
2019 ยฃ26.85 M315.86%
2018 ยฃ6.45 M2569.28%
2017 ยฃ0.24 M-97.3%
2016 ยฃ8.94 M293.9%
2015 ยฃ2.27 M-57.61%
2014 ยฃ5.35 M-21.43%
2013 ยฃ6.82 M13.49%
2012 ยฃ6.01 M-56.78%
2011 ยฃ13.9 M-10.37%
2010 ยฃ15.51 M-37.73%
2009 ยฃ24.91 M-1.56%
2008 ยฃ25.3 M256.78%
2007 ยฃ7.09 M186.68%
2006 ยฃ2.47 M-70.88%
2005 ยฃ8.49 M10.15%
2004 ยฃ7.71 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Agenus
AGEN
ยฃ80.13 M-67.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
ยฃ7.55 B 2,945.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
ยฃ48.18 B 19,334.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
ยฃ21.81 B 8,700.23%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
ยฃ43.60 B 17,486.85%๐Ÿ‡ฌ๐Ÿ‡ง UK
GlaxoSmithKline
GSK
ยฃ31.77 B 12,714.22%๐Ÿ‡ฌ๐Ÿ‡ง UK
Pfizer
PFE
ยฃ47.10 B 18,896.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
ยฃ12.58 B 4,975.73%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Amgen
AMGN
ยฃ26.98 B 10,783.35%๐Ÿ‡บ๐Ÿ‡ธ USA